Millennium Management’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-678
Closed -$56K 6203
2023
Q1
$56K Sell
678
-5,487
-89% -$539K ﹤0.01% 5590
2022
Q4
$528K Sell
6,165
-1,631
-21% -$147K ﹤0.01% 4704
2022
Q3
$722K Sell
7,796
-16,643
-68% -$1.79M ﹤0.01% 4628
2022
Q2
$3M Buy
24,439
+21,494
+730% +$2.52M ﹤0.01% 3306
2022
Q1
$344K Buy
+2,945
New +$487K ﹤0.01% 5435
2021
Q4
Sell
-1,111
Closed -$303K 6919
2021
Q3
$303K Buy
+1,111
New +$321K ﹤0.01% 5812
2021
Q2
Sell
-1,603
Closed -$618K 6627
2021
Q1
$618K Buy
+1,603
New +$722K ﹤0.01% 4644
2017
Q3
Sell
-29
Closed -$25K 3572
2017
Q2
$25K Buy
+29
New +$30.2K ﹤0.01% 3383
2016
Q3
Sell
-43
Closed -$89K 3318
2016
Q2
$89K Buy
+43
New +$87.8K ﹤0.01% 3034

Other funds holding DRIO

Millennium Management's DRIO Position: Q2 2023 in Review

Millennium Management sold out of DarioHealth (DRIO) in Q2 2023, closing a stake of 678 shares — an estimated $56K sold.

Millennium Management first reported a position in DRIO in Q2 2016 and held it in 9 quarters. The position peaked at $3M in Q2 2022. 45 funds tracked by Wall St. Rank hold DRIO as of Q2 2023.

  • Millennium Management reported no remaining DarioHealth position as of Q2 2023 after selling out during the quarter.
  • Millennium Management sold 678 DarioHealth shares in Q2 2023, an estimated $56K.
  • Millennium Management first reported a position in DarioHealth in Q2 2016 and held it in 9 quarters.
  • Millennium Management's DarioHealth position peaked at $3M in Q2 2022.
  • 45 funds tracked by Wall St. Rank held DarioHealth as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.